192 related articles for article (PubMed ID: 8232104)
1. The mevalonate pathway: importance in mesangial cell biology and glomerular disease.
O'Donnell MP; Kasiske BL; Kim Y; Atluru D; Keane WF
Miner Electrolyte Metab; 1993; 19(3):173-9. PubMed ID: 8232104
[TBL] [Abstract][Full Text] [Related]
2. Lovastatin inhibits proliferation of rat mesangial cells.
O'Donnell MP; Kasiske BL; Kim Y; Atluru D; Keane WF
J Clin Invest; 1993 Jan; 91(1):83-7. PubMed ID: 8423236
[TBL] [Abstract][Full Text] [Related]
3. Effects of lipids on the pathogenesis of progressive renal failure: role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in the prevention of glomerulosclerosis.
Guijarro C; Keane WF
Miner Electrolyte Metab; 1996; 22(1-3):147-52. PubMed ID: 8676808
[TBL] [Abstract][Full Text] [Related]
4. Regulation of proliferation and Ras localization in transformed cells by products of mevalonate metabolism.
Cuthbert JA; Lipsky PE
Cancer Res; 1997 Aug; 57(16):3498-505. PubMed ID: 9270019
[TBL] [Abstract][Full Text] [Related]
5. Lipids and progressive renal failure.
Keane WF
Wien Klin Wochenschr; 1996; 108(14):420-4. PubMed ID: 8784983
[TBL] [Abstract][Full Text] [Related]
6. Effect of inhibition of cholesterol synthetic pathway on the activation of Ras and MAP kinase in mesangial cells.
Bassa BV; Roh DD; Vaziri ND; Kirschenbaum MA; Kamanna VS
Biochim Biophys Acta; 1999 Mar; 1449(2):137-49. PubMed ID: 10082972
[TBL] [Abstract][Full Text] [Related]
7. Lovastatin inhibits lipopolysaccharide-induced NF-kappaB activation in human mesangial cells.
Guijarro C; Kim Y; Schoonover CM; Massy ZA; O'Donnell MP; Kasiske BL; Keane WF; Kashtan CE
Nephrol Dial Transplant; 1996 Jun; 11(6):990-6. PubMed ID: 8671958
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol synthesis inhibitors inhibit more than cholesterol synthesis.
Kasiske BL; O'Donnell MP; Kim Y; Atluru D; Keane WF
Kidney Int Suppl; 1994 Feb; 45():S51-3. PubMed ID: 8158898
[TBL] [Abstract][Full Text] [Related]
9. Low-density lipoprotein-induced expression of interleukin-6, a marker of human mesangial cell inflammation: effects of oxidation and modulation by lovastatin.
Massy ZA; Kim Y; Guijarro C; Kasiske BL; Keane WF; O'Donnell MP
Biochem Biophys Res Commun; 2000 Jan; 267(2):536-40. PubMed ID: 10631097
[TBL] [Abstract][Full Text] [Related]
10. Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-beta1 expression via a decrease in Ras/extracellular signal-regulated kinase activity in mesangial cells.
Song CY; Kim BC; Lee HS
Transl Res; 2008 Jan; 151(1):27-35. PubMed ID: 18061125
[TBL] [Abstract][Full Text] [Related]
11. Posttranscriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in lens epithelial cells by mevalonate-derived nonsterols.
Cenedella RJ
Exp Eye Res; 1997 Jul; 65(1):63-72. PubMed ID: 9237866
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effects of lovastatin on the proliferation and cell cycle phase of cultured human glomerular mesangial cells in vitro].
Li H; Li XW; Duan L; Li CH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Feb; 24(1):63-6. PubMed ID: 12905842
[TBL] [Abstract][Full Text] [Related]
13. Geranylgeraniol restores cell proliferation to lovastatin treated C6 glial cells.
Crick DC; Waechter CJ; Andres DA
SAAS Bull Biochem Biotechnol; 1996; 9():37-42. PubMed ID: 8652130
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.
Bouterfa HL; Sattelmeyer V; Czub S; Vordermark D; Roosen K; Tonn JC
Anticancer Res; 2000; 20(4):2761-71. PubMed ID: 10953355
[TBL] [Abstract][Full Text] [Related]
15. Farnesyl acetate, a derivative of an isoprenoid of the mevalonate pathway, inhibits DNA replication in hamster and human cells.
Meigs TE; Sherwood SW; Simoni RD
Exp Cell Res; 1995 Aug; 219(2):461-70. PubMed ID: 7641798
[TBL] [Abstract][Full Text] [Related]
16. Activation of the cholesterol pathway and Ras maturation in response to stress.
Shack S; Gorospe M; Fawcett TW; Hudgins WR; Holbrook NJ
Oncogene; 1999 Oct; 18(44):6021-8. PubMed ID: 10557091
[TBL] [Abstract][Full Text] [Related]
17. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention.
Mo H; Elson CE
Exp Biol Med (Maywood); 2004 Jul; 229(7):567-85. PubMed ID: 15229351
[TBL] [Abstract][Full Text] [Related]
18. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
[TBL] [Abstract][Full Text] [Related]
19. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells.
Choi JW; Jung SE
J Pharmacol Exp Ther; 1999 Apr; 289(1):572-9. PubMed ID: 10087052
[TBL] [Abstract][Full Text] [Related]
20. Effect of lipids on glomerular injury and progression of renal disease.
Keane WF
Verh K Acad Geneeskd Belg; 1994; 56(2):91-104. PubMed ID: 8048270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
